Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-13T05:26:33.856Z Has data issue: false hasContentIssue false

Compliance with antidepressant medication

Published online by Cambridge University Press:  02 January 2018

David Hall
Affiliation:
Department of Clinical Research Crichton Royal Hospital Dumfries DG1 4TG
David H. Wiles
Affiliation:
Department of Clinical Research Crichton Royal Hospital Dumfries DG1 4TG
Robin G. McCreadie
Affiliation:
Department of Clinical Research Crichton Royal Hospital Dumfries DG1 4TG
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1990 

References

Montgomery, S., McAuley, R. & Montgomery, D. B. (1977) Relationship between mianserin plasma levels and antidepressant effect in a double-blind trial comparing a single night-time and divided daily dose regimens. British Journal of Clinical Pharmacology, 5 (suppl. 1), 7176.Google Scholar
Myers, E. D. & Calvert, E. J. (1984) Information, compliance and side effects: a study of patients on antidepressant medication. British Journal of Clinical Pharmacology, 17, 2125.CrossRefGoogle ScholarPubMed
Orsulak, P. J. & Schildkraut, J. J. (1979) Guidelines for therapeutic monitoring of tricyclic antidepressant plasma levels. Therapeutic Drug Monitoring, 1, 199208.CrossRefGoogle ScholarPubMed
Voris, J. C., Morin, C. & Kiel, J. S. (1983) Monitoring outpatients' plasma antidepressant-drug concentrations as a measure of compliance. American JournalojHospitalPharmacy, 40, 119120.Google ScholarPubMed
Willcox, P. R. C., Gillan, R. & Hare, E. H. (1965) Do psychiatric patients take their drugs? British Medical Journal, ii, 790792.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.